Open AccessInhibition of MEK, a canonical KRAS pathway effector in KRAS mutant NSCLC
Author(s) -
Rafael Rosell,
Niki Karachaliou,
Carles Codony-Servat,
Masaoki Ito
Publication year - 2018
Publication title -
translational lung cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.474
H-Index - 41
eISSN - 2226-4477
pISSN - 2218-6751
DOI - 10.21037/tlcr.2018.03.20
Subject(s) - kras , effector , medicine , cancer research , mutant , lung cancer , computational biology , cancer , oncology , colorectal cancer , biology , genetics , immunology , gene